0001562180-17-001461.txt : 20170404 0001562180-17-001461.hdr.sgml : 20170404 20170404214117 ACCESSION NUMBER: 0001562180-17-001461 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170331 FILED AS OF DATE: 20170404 DATE AS OF CHANGE: 20170404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC CENTRAL INDEX KEY: 0001100412 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841460811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 3033816600 MAIL ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEFKOFF KYLE CENTRAL INDEX KEY: 0001191818 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16633 FILM NUMBER: 17740941 MAIL ADDRESS: STREET 1: 3200 WALNUT ST CITY: BOULDER STATE: CO ZIP: 80301 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2017-03-31 false 0001100412 ARRAY BIOPHARMA INC ARRY 0001191818 LEFKOFF KYLE C/O BOULDER VENTURES 1941 PEARL STREET, SUITE 300 BOULDER CO 80302 true false false false Common Stock 2016-11-28 5 G false E 2000.00 0.00 D 6585.00 D Common Stock 2017-03-31 4 M false 25000.00 3.69 A 31585.00 D Common Stock 2017-03-31 4 M false 20000.00 4.36 A 51585.00 D Common Stock 2017-03-31 4 S false 45000.00 8.92 D 6585.00 D Common Stock 45000.00 I See footnote Stock Option 3.69 2017-03-31 4 M false 25000.00 0.00 D 2022-04-25 Common Stock 25000.00 0.00 D Stock Option 4.36 2017-03-31 4 M false 20000.00 0.00 D 2013-10-24 2022-10-24 Common Stock 20000.00 0.00 D The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request. Comprised of 30,000 shares of common stock in trust for the benefit of Mr. Lefkoff's minor children and 15,000 shares of common stock held by BV Partners III Profit Sharing account for the benefit of Mr. Lefkoff. The option vested in 2 equal annual installments beginning on April 25, 2013. John Moore, attorney-in-fact for Reporting Person 2017-04-03